Page last updated: 2024-08-26

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Sepsis

4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol has been researched along with Sepsis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benowitz, NL; Bernard, GR; Calfee, CS; Havel, C; Jacob, P; Janz, DR; Kangelaris, KN; Matthay, MA; May, AK; Siew, ED; Ware, LB1

Other Studies

1 other study(ies) available for 4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol and Sepsis

ArticleYear
Cigarette Smoke Exposure and the Acute Respiratory Distress Syndrome.
    Critical care medicine, 2015, Volume: 43, Issue:9

    Topics: Adult; Aged; Alcoholism; APACHE; Biomarkers; Critical Illness; Diabetes Mellitus; Female; Humans; Male; Middle Aged; Nitrosamines; Prevalence; Prospective Studies; Pyridines; Racial Groups; Respiratory Distress Syndrome; Risk Factors; Sepsis; Smoking; Tertiary Care Centers; Time Factors; Tobacco Smoke Pollution

2015